Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05ZGW
|
||||
| Former ID |
DIB002398
|
||||
| Drug Name |
DPI-201-106
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Cardiovascular disorder [ICD10:I00-I99] | Terminated | [544559] | ||
| Company |
Novartis AG
|
||||
| Formula |
C29H30N4O2
|
||||
| Canonical SMILES |
c12c([nH]c(c1)C#N)cccc2OCC(CN1CCN(C(c2ccccc2)c2ccccc2)C<br />C1)O
|
||||
| CAS Number |
CAS 97730-95-5
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium channel | Target Info | Modulator | [531461] | |
| KEGG Pathway | Dopaminergic synapse | ||||
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.